VCU Massey Cancer Center

Menu

A Legacy of Innovation: Over 20 Years of Research Advances at VCU Massey Cancer Center

register to attend

Thursday, September 5, 2019

Omni Hotel Richmond
James River Ballroom
100 S. 12th St., Richmond, VA 23219

Please join Dr. Marsha Rappley, CEO of the VCU Health System, in honoring Dr. Gordon Ginder and his two-plus decades of leadership at VCU Massey Cancer Center. This research symposium will feature presentations highlighting the scientific achievements made at Massey under Dr. Ginder’s tenure as well as new directions for the future of cancer research. Seating is limited. Register early to attend.

For event questions, please contact:
Farah Mirza, MBA
(804) 628-1750
fmirza@vcu.edu

Symposium program

(subject to change)

View speaker bios

8:30–9:00 Breakfast
9:00–9:15

Welcome remarks
Michael Rao, Ph.D., president of VCU and VCU Health System
Marsha D. Rappley, M.D., CEO of VCU Health System and vice president of VCU Health Sciences

9:15–9:35 Massey’s research achievements in the last 20+ years
Steven Grossman, M.D., Ph.D., deputy director, Dianne Nunnally Hoppes Endowed Chair in Cancer Research and member of the Cancer Molecular Genetics and Developmental Therapeutics research programs at VCU Massey Cancer Center; professor and chair of the Division of Hematology, Oncology and Palliative Care at VCU School of Medicine
9:35–9:40 Video tribute to Dr. Ginder
9:40–12:10 Morning sessions: Hematologic cancers
9:40–9:50 Personal reflections on Dr. Ginder and speaker introduction
Richard Moran, Ph.D., emeritus researcher and leader at VCU Massey Cancer Center; professor emeritus of pharmacology and toxicology at VCU School of Medicine
9:50–10:20 Presentation of Massey science: “Targeting compensatory cytoprotective
pathways in hematologic malignancies”
Steven Grant, M.D., Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational research, co-leader and member of the Developmental Therapeutics research program and member of the Cancer Cell Signaling research program at VCU Massey Cancer Center; professor in the Division of Hematology, Oncology and Palliative Care at VCU School of Medicine
10:20–10:30 Personal reflections on Dr. Ginder and speaker introduction
John McCarty, M.D., director of Cellular Immunotherapies and Transplant and member of the Developmental Therapeutics research program at VCU Massey Cancer Center
10:30–11:00 Presentation of Massey science: “Exploring new frontiers in immunology, the interface of medicine and mathematics”
Amir Toor, M.D., member of the Developmental Therapeutics research program at VCU Massey Cancer Center; professor in the Division of Hematology, Oncology and Palliative Care at VCU School of Medicine
11:00–11:10 Personal reflections on Dr. Ginder and speaker introduction
Linda Burns, M.D., vice president and medical director of the Medical Services Department at the National Marrow Donor Program//Be The Match®; senior scientific director of the Health Services Research Program of the Center for International Blood & Marrow Transplant Research
11:10–12:10  Keynote presentation: “It all goes back to Globin”
Timothy Ley, M.D., Lewis T. and Rosalind B. Apple Chair in Oncology, professor of medicine, professor of genetics and director of the Stem Cell Biology Section in the Division of Oncology in the Department of Medicine at Washington University School of Medicine; member of the Siteman Cancer Center
12:10–1:00 Lunch
1:00–3:45 Afternoon sessions: Breast cancer
1:00–1:10 Personal reflections on Dr. Ginder and speaker introduction
Charles Geyer, Jr., M.D., Harrigan, Haw, Luck Families Chair in Cancer Research, associate director for clinical research and member of the Developmental Therapeutics research program at VCU Massey Cancer Center; professor in the Division of Hematology, Oncology and Palliative Care at VCU School of Medicine
1:10–2:10 Keynote presentation: "Tailored approaches to early-stage breast cancer: Reflections on 20 years of clinical progress"
Harold Burstein, M.D., Ph.D., professor of medicine at Harvard Medical School; Institute Physician at Dana-Farber Cancer Institute and Brigham & Women’s Hospital; member of the Breast Cancer Program at Dana-Farber Cancer Institute
2:10–2:20 Personal reflections on Dr. Ginder and speaker introduction
Charles Clevenger, M.D., Ph.D., Carolyn Wingate Hyde Chair and member of the Cancer Cell Signaling program at VCU Massey Cancer Center; chair and professor of the Department of Pathology at VCU School of Medicine
2:20–2:50 Presentation of Massey science: “Two decades of breast cancer and immunotherapy research – together at last”
Harry Bear, M.D., Ph.D., Walter Lawrence, Jr. Distinguished Professor in Oncology, chair of the Protocol Review & Monitoring Committee and member of the Developmental Therapeutics research program at VCU Massey Cancer Center; professor and chair of the Division of Surgical Oncology and professor of microbiology and immunology at VCU School of Medicine
2:50–3:00 Personal reflections on Dr. Ginder and speaker introduction
John Roberts, M.D., former Massey researcher and leader, medical director of the Yale New Haven Health Adult Sickle Cell Program and professor of internal medicine at Yale Medicine
3:00–3:30 Presentation of Massey science: “Accelerated partial breast irradiation: Massey Cancer Center's 25-year journey”  
Douglas Arthur, M.D., Florence and Hyman Meyers Endowed Chair in Radiation Oncology, associate director for clinical affairs and member of the Developmental Therapeutics research program at VCU Massey Cancer Center; professor and chair of the Department of Radiation Oncology at VCU School of Medicine
3:30–3:45

Closing remarks

Peter F. Buckley, M.D., dean of the VCU School of Medicine and executive vice president for medical affairs at VCU Health System
Marsha D. Rappley, M.D., CEO of VCU Health System and vice president of VCU Health Sciences

 

About Dr. Gordon Ginder

Gordon D. Ginder, M.D., has served as director of VCU Massey Cancer Center since 1997. After 22 years as one of the longest-standing National Cancer Institute-designated Cancer Center directors, he has announced his desire to step down as Massey's director. A national search is underway for his successor. He will remain at Massey as a scientist, where his lab focuses on epigenetics and regulation of genes in cancer and blood diseases, as a physician specialized in treating blood and lymph node cancers, and as a professor at the VCU School of Medicine. He will continue contributing to research, teaching and patient care.

Dr. Ginder leaves a lasting legacy that has impacted countless lives within and beyond our community. Under his leadership, Massey has taken on and maintained a trajectory of carefully planned steady growth, substantially building its scientific base and output fueled by a fourfold increase in extramural, philanthropic and state funding for life-saving cancer research. Reflecting these outstanding achievements, he successfully led five highly competitive renewals for Massey’s NCI designation. During his tenure, critical, state-of-the-art spaces for cancer research, training and care were developed across the university and health system, including the addition of Goodwin Research Laboratory, the first building at VCU dedicated solely to cancer research. He also oversaw the development of a strong research program in cancer prevention and control and strengthened multidisciplinary cancer care.

In 2003, Dr. Ginder was honored by the Governor and by the Science Museum of Virginia as Virginia’s Outstanding Scientist of the Year, and in 2015 he was bestowed the University Award of Excellence at VCU.